Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women
Nutrition & Metabolism - 2009
Tóm tắt
Acylation Stimulating Protein (ASP) has been shown to influence adipose tissue triglyceride (TG) storage. The aim was to examine ethnic differences in ASP and leptin levels in relation to lipid profiles and postprandial changes amongst African American (AA) and Caucasian American (CA) women matched for BMI. 129 women were recruited in total (age 21 – 73 y): 24 non-obese (BMI < 30 kg/m2) CA, 27 obese (BMI ≥ 30 kg/m2) CA, 13 obese diabetic CA, 25 non-obese AA, 25 obese AA, and 15 obese diabetic AA. Cholesterol, HDL-C, LDL-C, apoB, glucose and insulin were measured at baseline. TG, non-esterified fatty acids, leptin, and ASP were measured at baseline and postprandially following a fat meal. ASP, leptin, insulin and TG were significantly increased in obese subjects within each race. However, AA women had significantly lower ASP and TG than CA women at all BMI. Obese and diabetic AA women had significantly lower apoB levels than CA women when compared to their respective counterparts. For AA women, fasting ASP was positively correlated with BMI, cholesterol, apoB, LDL-C and glucose. For CA women, fasting ASP was positively correlated with BMI, leptin, glucose and insulin. However, for any given BMI, ASP was significantly reduced in AA vs CA (p = 0.0004). Similarly, for any given leptin level or TG levels, ASP was significantly lower in AA women (p = 0.041 and p = 0.003, respectively). CA women have higher baseline TG levels and an earlier TG peak that is accompanied with higher ASP levels suggesting increased ASP resistance, while AA women have lower baseline TG levels and a later TG peak at lower ASP levels suggesting increased ASP sensitivity. This may explain why AA women may have fewer metabolic complications, such as diabetes and CVD, when compared to their Caucasian counterparts at the same level of obesity.
Từ khóa
Tài liệu tham khảo
Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM: Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. J Am Med Assoc. 2004, 291: 2847-2850. 10.1001/jama.291.23.2847.
Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB: Years of life lost due to obesity. J Am Med Assoc. 2003, 289: 187-193. 10.1001/jama.289.2.187.
Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB: Annual deaths attributable to obesity in the United States. J Am Med Assoc. 1999, 282: 1530-1538. 10.1001/jama.282.16.1530.
Rose DP, Haffner SM, Baillargeon J: Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr Rev. 2007, 28: 763-777. 10.1210/er.2006-0019.
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 1998, 21: 518-524. 10.2337/diacare.21.4.518.
Osei K, Schuster DP: Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med. 1994, 11: 755-762.
Osei K, Cottrell DA: Minimal model analyses of insulin sensitivity and glucose-dependent glucose disposal in black and white Americans: a study of persons at risk for type 2 diabetes. Eur J Clin Invest. 1994, 24: 843-850. 10.1111/j.1365-2362.1994.tb02029.x.
Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX: Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes. 1997, 46: 456-462. 10.2337/diabetes.46.3.456.
Racette SB, Horowitz JF, Mittendorfer B, Klein S: Racial differences in lipid metabolism in women with abdominal obesity. Am J Physiol Regul Integr Comp Physiol. 2000, 279: R944-R950.
Uusitupa MI, Niskanen LK, Siitonen O, Voutilainen E, Pyorala K: 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 1990, 82: 27-36.
Sanchez AM, Reed DR, Price RA: Reduced mortality associated with body mass index (BMI) in African Americans relative to Caucasians. Ethn Dis. 2000, 10: 24-30.
Tittelbach TJ, Berman DM, Nicklas BJ, Ryan AS, Goldberg AP: Racial differences in adipocyte size and relationship to the metabolic syndrome in obese women. Obes Res. 2004, 12: 990-998. 10.1038/oby.2004.121.
Bower JF, Vadlamudi S, Barakat HA: Ethnic differences in in vitro glyceride synthesis in subcutaneous and omental adipose tissue. Am J Physiol Endocrinol Metab. 2002, 283: E988-E993.
Araneta MR, Barrett-Connor E: Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women. Obesity (Silver Spring). 2007, 15: 2454-2462. 10.1038/oby.2007.291.
Lu G, Chiem A, Anuurad E, Havel PJ, Pearson TA, Ormsby B, Berglund L: Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. Transl Res. 2007, 149: 317-323. 10.1016/j.trsl.2006.12.008.
Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA: Ethnic differences in adiponectin levels. Metabolism. 2004, 53: 1-3. 10.1016/j.metabol.2003.07.002.
Schutte AE, Huisman HW, Schutte R, Malan L, van Rooyen JM, Malan NT, Schwarz PE: Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol. 2007, 157: 181-188. 10.1530/EJE-07-0044.
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM: Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995, 269: 543-546. 10.1126/science.7624777.
Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 2002, 13: 51-59. 10.1097/00041433-200202000-00008.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans [see comments]. N Eng J Med. 1996, 334: 292-295. 10.1056/NEJM199602013340503.
Boden G, Chen X, Kolaczynski JW, Polansky M: Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. J Clin Invest. 1997, 100: 1107-1113s. 10.1172/JCI119621.
Weigle DS, Duell PB, Conner WE, Steiner RA, Soules MR, Kuijper JL: Effects of fasting, refeeding, and dietary fat restriction on plasma leptin levels. J Clin Endocrinol Metab. 1997, 82: 561-565. 10.1210/jc.82.2.561.
Madan AK, Tichansky DS, Coday M, Fain JN: Comparison of IL-8, IL-6 and PGE(2) formation by visceral (omental) adipose tissue of obese Caucasian compared to African-American women. Obes Surg. 2006, 16: 1342-1350. 10.1381/096089206778663652.
Jen KL, Buison A, Darga L, Nelson D: The relationship between blood leptin level and bone density is specific to ethnicity and menopausal status. J Lab Clin Med. 2005, 146: 18-24. 10.1016/j.lab.2005.02.014.
Nicklas BJ, Toth MJ, Goldberg AP, Poehlman ET: Racial differences in plasma leptin concentrations in obese postmenopausal women. J Clin Endocrinol Metab. 1997, 82: 315-317. 10.1210/jc.82.1.315.
Perry HM, Morley JE, Horowitz M, Kaiser FE, Miller DK, Wittert G: Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. Metabolism. 1997, 46: 1399-1405. 10.1016/S0026-0495(97)90138-4.
Folsom AR, Jensen MD, Jacobs DR, Hilner JE, Tsai AW, Schreiner PJ: Serum leptin and weight gain over 8 years in African American and Caucasian young adults. Obes Res. 1999, 7: 1-8.
Schutte R, Huisman HW, Schutte AE, Malan NT: Leptin is favourably associated with vascular function in obese Caucasians, but not in obese Africans. J Hum Hypertens. 2005, 19: 933-939. 10.1038/sj.jhh.1001922.
Smith J, Al-Amri M, Sniderman A, Cianflone K: Leptin and adiponectin in relation to body fat percentage, waist to hip ratio and the apoB/apoA1 ratio in Asian Indian and Caucasian men and women. Nutr Metab (Lond). 2006, 3: 18-10.1186/1743-7075-3-18.
Carroll JF, Fulda KG, Chiapa AL, Rodriquez M, Phelps DR, Cardarelli KM, Vishwanatha JK, Cardarelli R: Impact of Race/Ethnicity on the Relationship Between Visceral Fat and Inflammatory Biomarkers. Obesity (Silver Spring). 2009,
Hyatt TC, Phadke RP, Hunter GR, Bush NC, Muñoz AJ, Gower BA: Insulin sensitivity in African-American and white women: association with inflammation. Obesity (Silver Spring). 2009, 17: 276-282. 10.1038/oby.2008.549.
Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD: Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res. 2000, 41: 1963-1968.
Saleh J, Sniderman AD, Cianflone K: Postprandial triacylglycerol clearance in ob/ob and db/db mice: physiological effects of ASP in mouse models of obesity and hypertriglyceridemia (Abstract). Int J Obesity Rel Metab Dis. 1998, 22: s-183.
Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD: The adipsin/acylation stimulating protein system in human adipocytes: Regulation of triacylglycerol synthesis. Biochemistry. 1994, 33: 9489-9495. 10.1021/bi00198a014.
Cianflone K, Xia Z, Chen LY: Critical review of Acylation Stimulating Protein physiology in humans and rodents. Biochim Biophys Acta. 2003, 1609: 127-143. 10.1016/S0005-2736(02)00686-7.
Kalant D, Maclaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K: C5L2 is a functional receptor for acylation stimulating protein. J Biol Chem. 2005, 280: 23936-23944. 10.1074/jbc.M406921200.
Kalant D, Cain SA, Maslowska M, Sniderman AD, Cianflone K, Monk PN: The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/Acylation-Stimulating Protein. J Biol Chem. 2003, 278: 11123-11129. 10.1074/jbc.M206169200.
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997, 20: 1183-1197.
Bower JF, Deshaies Y, Pfeifer M, Tanenberg RJ, Barakat HA: Ethnic differences in postprandial triglyceride response to a fatty meal and lipoprotein lipase in lean and obese African American and Caucasian women. Metabolism. 2002, 51: 211-217. 10.1053/meta.2002.29991.
Humphreys SM, Fisher RM, Frayn KN: Micro-method measurement of sub-nanomole amounts of triacylglycerol. Ann Clin Biochem. 1990, 27: 597-598.
Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982, 23: 1206-1223.
Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D, Cianflone K: Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest. 1999, 29: 679-686. 10.1046/j.1365-2362.1999.00514.x.
Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN: Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res. 1998, 39: 884-891.
Schectman G, Patsches M, Sasse EA: Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations. Clin Chem. 1996, 42: 732-737.
Hickner RC, Privette J, McIver K, Barakat H: Fatty acid oxidation in African-American and Caucasian women during physical activity. J Appl Physiol. 2001, 90: 2319-2324.
Privette JD, Hickner RC, MacDonald KG, Pories WJ, Barakat HA: Fatty acid oxidation by skeletal muscle homogenates from morbidly obese black and white American women. Metabolism. 2003, 52: 735-738. 10.1016/S0026-0495(03)00034-9.
Albu JB, Curi M, Shur M, Murphy L, Matthews DE, Pi-Sunyer FX: Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity. Am J Physiol. 1999, 277: E551-E560.
Barakat H, Hickner RC, Privette J, Bower J, Hao E, Udupi V, Green A, Pories W, MacDonald K: Differences in the lipolytic function of adipose tissue preparations from Black American and Caucasian women. Metabolism. 2002, 51: 1514-1518. 10.1053/meta.2002.35589.
McConnaughey MM, Sheets KA, Davis J, Privette J, Hickner R, Christian B, Barakat H: Differences in beta-adrenergic receptor densities in omental and subcutaneous adipose tissue from obese African American and Caucasian women. Metabolism. 2004, 53: 247-251. 10.1016/j.metabol.2003.09.014.
Galvin VB, Barakat H, Kemeny G, MacDonald KG, Pories WJ, Hickner RC: Endothelial nitric oxide synthase content in adipose tissue from obese and lean African American and white American women. Metabolism. 2005, 54: 1368-1373. 10.1016/j.metabol.2005.04.028.
Barakat H, Davis J, Lang D, Mustafa SJ, McConnaughey MM: Differences in the expression of the adenosine A1 receptor in adipose tissue of obese black and white women. J Clin Endocrinol Metab. 2006, 91: 1882-1886. 10.1210/jc.2005-2109.
Bower JF, Davis JM, Hao E, Barakat HA: Differences in transport of fatty acids and expression of fatty acid transporting proteins in adipose tissue of obese black and white women. Am J Physiol Endocrinol Metab. 2006, 290: E87-E91. 10.1152/ajpendo.00194.2005.
Faraj M, Sniderman AD, Cianflone K: ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J Lipid Res. 2004, 45: 657-666. 10.1194/jlr.M300299-JLR200.
Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL: Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord. 1998, 22: 39-47. 10.1038/sj.ijo.0800541.
Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman A: Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res. 2004, 45: 124-131. 10.1194/jlr.M300214-JLR200.
Yu H, Yang Y, Zhang M, Lu H, Zhang J, Wang H, Cianflone K: Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab (Lond). 2006, 3: 13-10.1186/1743-7075-3-13.
Tahiri Y, Karpe F, Tan GD, Cianflone K: Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutr Metab (Lond). 2007, 4: 11-10.1186/1743-7075-4-11.